Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb;95(Pt 2):408-412.
doi: 10.1099/vir.0.060640-0. Epub 2013 Nov 6.

Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus

Christopher M Coleman  1 , Krystal L Matthews  1 , Lindsay Goicochea  2 , Matthew B Frieman  1
Affiliations

Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus

Christopher M Coleman et al. J Gen Virol. 2014 Feb.

Abstract

The Middle East respiratory syndrome coronavirus (MERS-CoV) is a newly emerging highly pathogenic virus causing almost 50 % lethality in infected individuals. The development of a small-animal model is critical for the understanding of this virus and to aid in development of countermeasures against MERS-CoV. We found that BALB/c, 129/SvEv and 129/SvEv STAT1 knockout mice are not permissive to MERS-CoV infection. The lack of infection may be due to the low level of mRNA and protein for the MERS-CoV receptor, dipeptidyl peptidase 4 (DPP4), in the lungs of mice. The low level of DPP4 in the lungs likely contributes to the lack of viral replication in these mouse models and suggests that a transgenic mouse model expressing DPP4 to higher levels is necessary to create a mouse model for MERS-CoV.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
MERS-CoV pathogenesis in mice. Weight-loss curves of BALB/c (a), 129Sv/Ev (b) or 129/STAT1−/− mice (c) after either mock infection with PBS or MERS-CoV at two inoculum doses. (d, e) Lung homogenate from infected mice in (a–c) was assayed for the presence of virus at multiple time points after infection. Dotted line notes the level of detection in our TCID50 assays. RNA was extracted from mouse lungs during infection and assayed for amount of viral RNA present during infection by real-time PCR analysis of the envelope ORF (f, g) or 1B(h, i). RNA from BALB/c mice (f, h) and RNA from 129Sv/Ev and 129/STAT1−/− mice (g, i) were assayed. Three mice at each time point and condition were used for each averaged value. Primers specific to the leader primer of MERS-CoV were used for real-time PCR analysis to identify subgenomic RNA as a reporter of viral replication (j, k). *P-value >0.5, P-value <0.5.
Fig. 2.
Fig. 2.
Histological analysis of MERS-CoV infected mice. (a) Histology of H&E stained lungs of BALB/c mice infected with MERS-CoV at 2 and 4 days p.i. (b) Histology of H&E stained lungs of 128/SvEv and 129/STAT1−/− mice infected with MERS-CoV at 9 days p.i.
Fig. 3.
Fig. 3.
DPP4 expression levels in mice. IHC staining of BALB/c mouse intestines (a) and lung (b) was performed with anti-DPP4 antibody at 1/100 dilution using antigen retrieval. We find significant levels of DPP4 protein expression in mouse intestines compared to secondary only control tissue; however, in mouse lungs we observe minimal DPP4 staining in airways or alveolar cells. (c) Real-time PCR analysis of DPP4 mRNA from intestines and lungs of mice compared to actin mRNA levels as a control.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chan J. F., Chan K. H., Choi G. K., To K. K., Tse H., Cai J. P., Yeung M. L., Cheng V. C., Chen H. & other authors (2013). Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis 207, 1743–1752 10.1093/infdis/jit123 - DOI - PMC - PubMed
    1. Corman V. M., Eckerle I., Bleicker T., Zaki A., Landt O., Eschbach-Bludau M., van Boheemen S., Gopal R., Ballhause M. & other authors (2012a). Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Eurosurveillance 17, 39. - PubMed
    1. Corman V. M., Muller M. A., Costabel U., Timm J., Binger T., Meyer B., Kreher P., Lattwein E., Eschbach-Bludau M. & other authors (2012b). Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Eurosurveillance 17, 49 - PubMed
    1. de Wit E., Prescott J., Baseler L., Bushmaker T., Thomas T., Lackemeyer M. G., Martellaro C., Milne-Price S., Haddock E. & other authors (2013). The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters. PLoS ONE 8, e69127 10.1371/journal.pone.0069127 - DOI - PMC - PubMed
    1. Drosten C., Seilmaier M., Corman V. M., Hartmann W., Scheible G., Sack S., Guggemos W., Kallies R., Muth D. & other authors (2013). Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 13, 745–751 10.1016/S1473-3099(13)70154-3 - DOI - PMC - PubMed

Publication types

-